Pubdate: Mon, 25 Jun 2001 Source: American Medical News (US) Copyright: 2001, American Medical Association Contact: http://www.ama-assn.org/public/journals/amnews/edlet.htm Website: http://www.amednews.com/ Details: http://www.mapinc.org/media/1235 Author: Tanya Albert, AMNews staff NEVADA APPROVES BILL ON MEDICAL USE OF MARIJUANA The legislation isn't expected to raise problems with federal authorities, but the state medical association opposes it. Despite the recent U.S. Supreme Court ruling that put the kibosh on California's cannabis buying clubs, the Nevada Legislature earlier this month voted to legalize the medical use of marijuana there. The key difference in Nevada's system that some experts say should allow the legislation to go forward without much, if any, interference from the federal government is the way the law lets patients access medical marijuana. Unlike California's buying clubs, where large amounts of marijuana were grown in a central location and then distributed to patients, Nevada's legislation would allow patients or their caregivers to have up to seven plants for their personal use. It's similar to laws in Oregon and Maine in that respect, and neither of those states has encountered problems with the federal government before or after the May high court ruling. "Our analysis is that the Supreme Court ruling said there is no medical necessity defense and that buying clubs weren't legal," said Brenda Erdes, legislative counsel with Nevada's Legislative Counsel Office, which directed the state Legislature on the best way to write the law without running into problems. "But there wasn't anything beyond that." The court ruling didn't strike down laws or ballot initiatives that passed in nine states in recent years, including California. And in Oregon and Maine, where medical marijuana programs have been up and running for several years, the ruling hasn't changed physician habits when it comes to recommending whether patients should be allowed to have marijuana for medical purposes. "We've received no questions to our knowledge," said Jim Kronenberg, spokesman for the Oregon Medical Assn. "The atmosphere is unchanged," added Kevin Neely, spokesman for the Oregon Attorney General's Office. "Physicians have always been wary because they are subject to federal laws." Buffering physicians But Oregon has tried to make physicians feel more confident that they won't get in trouble with federal authorities. Oregon law requires patients to get a note from their doctor, which they can bring to the state to receive a license which allows them to own marijuana plants, Neely said. About 2,300 cards have been issued. Nevada's legislation, which at press time was waiting for the governor's expected signature, tries to do something similar. In addition to letting patients cultivate seven plants, the state would create a registry for patients whose physicians recommended that they use medical marijuana to treat side effects of their serious illnesses. Nevada also would take things a step further than other states have. It plans to ask the federal government for permission to conduct research on whether marijuana helps ease pain, nausea and other problems that people with cancer, AIDS and other serious illnesses encounter. Despite the research component of the legislation, the Nevada State Medical Assn. continues to oppose legalizing medical marijuana. The medical benefits haven't been shown, and the federal government would have to change its policies for the drug to be legal, said NSMA Executive Director Lawrence P. Matheis. "It simply is a popular vote," he said. "It's empathy for people who are chronically ill. There is question to whether there is any medical value. ... The [state] constitution is a terrible place to put a medical directive." Las Vegas oncologist Arnold Wax, MD, agreed. He pointed to a study in the July 1, 2000, Journal of Immunology that found that the active ingredient in marijuana actually caused cancer cells to reproduce faster. And, he said, there are plenty of other legal drugs on the market to treat patients, including Marinol (dronabinol), manufactured by Roxane Laboratories Inc. and Unimed Pharmaceuticals Inc. Marinol is the synthetic form of THC, the active ingredient in marijuana. "There is absolutely no use for [medical marijuana]," he said. "It is a social and emotional issue. It is not a medical issue." - --- MAP posted-by: Keith Brilhart